Will Ask States To Use Rs 31,000 Crore Fund For Building Workers, Says Centre
Union Finance Minister Nirmala Sitharaman on Thursday said that the Centre will direct state governments to utilise the construction workers' welfare fund to support these workers against economic disruption due to the 21-day lockdown in the wake of the coronavirus crisis. Addressing the media here, Sitharaman said that the fund created by a central government's Act currently has about Rs 31,000 crore in it. A total of around 3.5 crore workers are registered under the Act.
"Obviously, because of the way we have taken a call to contain the coronavirus with a lockdown so that people stay at home and don't expose themselves to the risk, as a result, many building and construction workers may be feeling the impact because their work has come to a halt," she said.
"There is a welfare fund for building and other construction workers' welfare. We intend to give directions to the states to utilize this fund to provide assistance and support to those workers in the construction and building sectors to protect them against any economic disruption."
Several experts and industry players, including developers, had demanded economic support to the construction workers whose work has come to a standstill due to the lockdown.
Along with other major announcements, the minister also announced that the government has directed states to use district mineral fund for the coronavirus medical expenses.
States will use district mineral fund for medical screening, facilities, and healthcare needs, she said.
Concerns have been raised in the past few days over the medical infrastructure in the country to deal with the disease and the required funds for the requisite facilities.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.